ClinicalTrials.Veeva

Menu

EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs (EVLP-DCD)

P

Policlinico Hospital

Status and phase

Unknown
Phase 1

Conditions

Graft Failure
Disorders Related to Lung Transplantation

Treatments

Procedure: EVLP-DCD Group

Study type

Interventional

Funder types

Other

Identifiers

NCT02061462
EVLP_2013

Details and patient eligibility

About

The procurement of organs from donors after cardiocirculatory death (DCD) is an accepted strategy to increase organ supply.

Full description

Aim of the investigation: to compare the clinical outcome after transplantation of subjects receiving lungs procured from donors after cardiocirculatory death reconditioned and assessed by EVLP, with that of subjects receiving lungs procured from brain death donors.

Enrollment

10 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Lung donors:

  • subjects with brain death according to neurological or cardiocirculatory criteria
  • age below 65 yrs
  • absence of massive lung contusion, aspiration, pneumonia, sepsis
  • absence of infection, malignancy

Recipients:

  • subjects to undergo single or bilateral lung transplantation
  • informed consent to participate in the study

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Standard Group
No Intervention group
Description:
Recipients of lungs procured from brain dead donors.
EVLP-DCD Group
Active Comparator group
Description:
Recipients of lungs procured from DCD donors, reconditioned/evaluated by EVLP
Treatment:
Procedure: EVLP-DCD Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems